[Updated from February 2018 post] Mobile technology lends many benefits to clinical research, including shortened study duration, more accurate data, and beyond. Keep reading for our perspective on the impact we can expect mobile apps to have as the industry advances.
In this guest post from TruLab, Inc., Lindsey Lanier walks us through the problems with the current approach to bio sample management and how we can increase efficiencies and achieve better outcomes by leveraging the latest in technology – including blockchain.
CDS has many innovative updates in store for TrialKit in 2021. Check out this blog post for a quick glance at what’s to come to the platform in the upcoming year.
The trends infiltrating the clinical research industry – wearable integrations, mobile apps, machine learning, and more – aren’t just exciting concepts. They’re made possible and are now being used in studies with today’s technology.
What are the current challenges in the clinical industry today, and what steps can we take to overcome them? This blog post recounts the discussion our panel of experts had on this very topic in our recent webinar, Bridging the Gap to the New Clinical Trial Landscape.
A new wave of interest in virtual trials has been generated by the coronavirus pandemic. But will the enthusiasm remain after the conclusion of the pandemic? In this post, we provide our perspective on why the virtual trial may be here to stay.
Making patient engagement more achievable will lead to more successful clinical trials. In this post, we detail four best practices in the TrialKit platform to help research teams reach optimal patient engagement.
With growing interest in virtual trials comes the need for technology to support it. Keep reading to learn how TrialKit’s inherent design is ideal for data collection and study management in the virtual trial space.
A newer technique to the industry, bring your own device is approached with apprehension. In this post, we’ve identified four misconceptions about BYOD and provided explanations on each.